BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32736084)

  • 1. Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects.
    Elmadany N; Logiacco F; Buonfiglioli A; Haage VC; Wright-Jin EC; Schattenberg A; Papawassiliou RM; Kettenmann H; Semtner M; Gutmann DH
    Neurobiol Dis; 2020 Oct; 144():105030. PubMed ID: 32736084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.
    Kuhrt LD; Motta E; Elmadany N; Weidling H; Fritsche-Guenther R; Efe IE; Cobb O; Chatterjee J; Boggs LG; Schnauß M; Diecke S; Semtner M; Anastasaki C; Gutmann DH; Kettenmann H
    Dis Model Mech; 2023 Dec; 16(12):. PubMed ID: 37990867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.
    Logiacco F; Grzegorzek LC; Cordell EC; Popp O; Mertins P; Gutmann DH; Kettenmann H; Semtner M
    Acta Neuropathol Commun; 2023 Mar; 11(1):36. PubMed ID: 36890585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
    Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
    Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
    Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
    Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
    Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N
    Elife; 2022 Mar; 11():. PubMed ID: 35311647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.
    Warrington NM; Sun T; Luo J; McKinstry RC; Parkin PC; Ganzhorn S; Spoljaric D; Albers AC; Merkelson A; Stewart DR; Stevenson DA; Viskochil D; Druley TE; Forys JT; Reilly KM; Fisher MJ; Tabori U; Allen JC; Schiffman JD; Gutmann DH; Rubin JB
    Cancer Res; 2015 Jan; 75(1):16-21. PubMed ID: 25381154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.
    Anastasaki C; Gutmann DH
    Hum Mol Genet; 2014 Dec; 23(25):6712-21. PubMed ID: 25070947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
    Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
    Diggs-Andrews KA; Brown JA; Gianino SM; Rubin JB; Wozniak DF; Gutmann DH
    Ann Neurol; 2014 Feb; 75(2):309-16. PubMed ID: 24375753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.
    Elmadany N; de Almeida Sassi F; Wendt S; Logiacco F; Visser J; Haage V; Hernandez DP; Mertins P; Hambardzumyan D; Wolf S; Kettenmann H; Semtner M
    J Neurosci; 2020 Apr; 40(17):3320-3331. PubMed ID: 32060170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.
    Toonen JA; Anastasaki C; Smithson LJ; Gianino SM; Li K; Kesterson RA; Gutmann DH
    Hum Mol Genet; 2016 May; 25(9):1703-13. PubMed ID: 26908603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.
    Diggs-Andrews KA; Tokuda K; Izumi Y; Zorumski CF; Wozniak DF; Gutmann DH
    Ann Neurol; 2013 Feb; 73(2):309-15. PubMed ID: 23225063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
    Dasgupta B; Dugan LL; Gutmann DH
    J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
    Daginakatte GC; Gutmann DH
    Hum Mol Genet; 2007 May; 16(9):1098-112. PubMed ID: 17400655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
    Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
    Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct P2Y Receptors Mediate Extension and Retraction of Microglial Processes in Epileptic and Peritumoral Human Tissue.
    Milior G; Morin-Brureau M; Chali F; Le Duigou C; Savary E; Huberfeld G; Rouach N; Pallud J; Capelle L; Navarro V; Mathon B; Clemenceau S; Miles R
    J Neurosci; 2020 Feb; 40(7):1373-1388. PubMed ID: 31896671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1.
    Wolman MA; de Groh ED; McBride SM; Jongens TA; Granato M; Epstein JA
    Cell Rep; 2014 Sep; 8(5):1265-70. PubMed ID: 25176649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.
    Apostolova I; Niedzielska D; Derlin T; Koziolek EJ; Amthauer H; Salmen B; Pahnke J; Brenner W; Mautner VF; Buchert R
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1304-12. PubMed ID: 25785829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.
    Brown JA; Gianino SM; Gutmann DH
    J Neurosci; 2010 Apr; 30(16):5579-89. PubMed ID: 20410111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.